International Finance Facility for Immunisation

What International Finance Facility for Immunisation does

The International Finance Facility for Immunisation (IFFIm) is a multilateral development finance mechanism established in 2006 that operates as the world's first social bond programme. IFFIm raises capital by issuing Vaccine Bonds in global capital markets — across US dollar, euro, pound sterling, and Japanese retail (uridashi) markets — and converts long-term sovereign pledges from government donors into immediate funding for Gavi, the Vaccine Alliance, which then channels the resources into immunisation programmes in 73 low-income countries. Since inception IFFIm has raised over US$ 10.3 billion, helping Gavi immunise 1.2 billion children and save an estimated 20.6 million lives. The organisation has also pioneered Islamic finance through Sukuk issuances (first in 2014, second US$ 200 million in 2016) to broaden its investor base.

IFFIm's core product is the Vaccine Bond, a social impact bond structured around sovereign pledges from donor governments including the United Kingdom, France, Italy, Spain, Sweden, Norway, Australia, Brazil, Canada, and the Netherlands. The World Bank serves as treasury manager and provides governance oversight; UNICEF and WHO act as implementation partners within Gavi's delivery chain. IFFIm does not generate revenue in the commercial sense — it does not charge fees to recipient countries, and investors in Vaccine Bonds receive market-based returns funded by sovereign donor commitments. The organisation holds AA/AA- credit ratings from Fitch (Stable outlook) and an A+ rating from the UK FCDO for seven consecutive years, and its 2017 issuance was named 'Deal of the Year' in the social bond category.

IFFIm's business model is a frontloading mechanism: by issuing bonds against confirmed long-term donor pledges, it accelerates the availability of capital for vaccines compared with waiting for incremental donor disbursements. Recent issuance cadence has accelerated materially, including a record-breaking US$ 1 billion bond in November 2024 directed to Gavi and CEPI, a US$ 250 million tap in 2024, and a US$ 1 billion issuance in December 2021. The organisation publishes an IFFIm Investment Case for Gavi 2026-2030 to support donor replenishment, and has expanded its vaccine portfolio to include polio, pentavalent, pneumococcal, HPV, yellow fever, meningitis, and malaria programmes.

Name

International Finance Facility for Immunisation

Legal name

International Finance Facility for Immunisation

Website

https://iffim.org

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

IFFIm is a multilateral development finance mechanism (founded 2006) that issues Vaccine Bonds in global capital markets to convert long-term sovereign donor pledges into immediate funding for Gavi, the Vaccine Alliance, supporting immunisation programmes in 73 low-income countries.

Ownership category

akta.pro rank

Product category

Development Finance

NAICS

Investment Banking and Securities Intermediation (523150)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Asset-Backed Securities (6189)

akta.pro primary industry

Private Sector & Blended Finance Arms (IFC-type) (BPADACAJ)

akta.pro secondary industries

Immunization & Vaccine Access Partnerships (Global Vaccine Alliances) (HLAJAOAF), Funding, Reimbursement & Vaccines-for-Children (VFC)/Public Purchase Programs (HLAJAHAK), Bilateral Development Finance Institutions (DFIs) (BPADACAD)

Keywords

• Vaccine bonds
• Social impact bonds
• Development finance
• Immunisation funding
• Sovereign-backed bonds

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Others

Revenue model

1. Vaccine Bond Issuance: IFFIm raises capital by issuing Vaccine Bonds in global capital markets. These social bonds convert long-term donor pledges into immediate funding for immunisation programmes. Investors receive market-based returns while funds are deployed to Gavi-supported programmes in low-income countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

IFFIm is a multilateral development finance organisation that issues Vaccine Bonds (and Vaccine Sukuks) in global capital markets to convert long-term sovereign donor pledges into immediate funding for Gavi, the Vaccine Alliance. Proceeds are channelled to Gavi to accelerate the delivery of life-saving vaccines to children in the world's poorest countries. Since 2006, IFFIm has raised over US$10.3 billion across multiple issuances in USD, EUR, GBP, and Japanese retail markets.

Product overview

IFFIm operates as the world's first social bond programme, using Vaccine Bonds as its core product to mobilise private sector capital for global immunisation. The organisation raises funds through bond issuances in global capital markets and channels them immediately to Gavi, the Vaccine Alliance, to accelerate vaccine delivery to children in the poorest countries. IFFIm has raised over $10.3 billion, enabling Gavi to immunise 1.2 billion children and save 20.6 million lives. The portfolio includes funding for various vaccines including polio ($426M), malaria ($108M), HPV ($165M), pentavalent (over $1 billion), pneumococcal ($200M), yellow fever ($90.9M), and meningitis ($62M). IFFIm also provides Health System Strengthening support ($277M) to build healthcare infrastructure in supported countries.

Differentiator

Problem solved

Functional benefit

Brands

• Vaccine Bonds: IFFIm's flagship social bond product that converts long-term donor pledges into immediate funding for immunization programs. Vaccine Bonds provide market-based returns to investors while delivering social impact through funding Gavi's vaccine programs worldwide.

Products and services

• Vaccine Bonds IFFIm's flagship social bond product that converts long-term sovereign pledges from government donors into immediate funding for Gavi immunisation programmes. Investors receive market-based returns while proceeds are deployed to Gavi-supported vaccine programmes in low-income countries. Issued in multiple currencies (USD, EUR, GBP, JPY).
• Vaccine Sukuks (Islamic Finance) Shariah-compliant bond instrument issued by IFFIm to access Islamic finance investors. The second Sukuk raised US$200 million, broadening the investor base for immunisation funding.
• Gavi Immunisation Funding Channel Mechanism through which IFFIm channels capital raised via Vaccine Bonds to Gavi, funding programmes including polio, malaria, HPV, pentavalent, pneumococcal, yellow fever, and meningitis vaccines, as well as health system strengthening.

Quantifiable outcome

• 1.2 billion children immunised
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• Gavi, the Vaccine AlliancecoreStrategic or Co-development PartnerIFFIm's primary beneficiary is Gavi, the Vaccine Alliance. IFFIm raises funds through Vaccine Bonds and disburses them to Gavi to support immunisation programmes in low-income countries. This is IFFIm's core purpose and primary partnership.
• World BankcoreStrategic or Co-development PartnerThe World Bank serves as IFFIm's treasury manager and provides governance oversight. The World Bank Group manages IFFIm's financial operations and acts as a key institutional partner.
• UNICEFcoreImplementation/ SI/ Consulting PartnerUNICEF is a key implementation partner for Gavi-supported immunisation programmes, delivering vaccines and supporting health system strengthening in recipient countries.
• World Health Organization (WHO)coreImplementation/ SI/ Consulting PartnerWHO provides technical and normative guidance for immunisation programmes supported by Gavi funding from IFFIm.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• KfW (Kreditanstalt für Wiederaufbau): KfW is a major German state-backed development bank that issues AAA-rated bonds in capital markets to fund development and climate programmes. It is comparable in mechanism (sovereign-backed bond issuance for development finance) though broader in mandate.
• International Finance Corporation (IFC): IFC is the World Bank Group's private-sector development arm and the closest archetype for IFFIm: it mobilises private capital into development outcomes via structured/blended finance, including bond programmes. Both are housed within/adjacent to the World Bank and deploy capital-market proceeds for development impact.
• European Investment Bank (EIB): EIB is a large supranational issuer of EUR-denominated bonds used to fund development, climate and health-related projects. Comparable in capital-markets scale, sovereign backing, and use of bond proceeds for impact-oriented lending.
• Asian Infrastructure Investment Bank (AIIB): AIIB is a multilateral development bank issuing bonds in capital markets to finance infrastructure and development across member countries. Comparable as a multilateral, capital-markets-funded development financier with sovereign backers.
• World Bank (IBRD/IDA): The World Bank acts as IFFIm's treasury manager and is a peer in raising multi-currency development funding in capital markets (e.g., IDA bonds). Both issue bonds backed by sovereign commitments to fund low-income-country programmes.

Regional players

• African Development Bank (AfDB): AfDB is a multilateral development bank that issues bonds to fund development across Africa, a geography heavily served by IFFIm-funded Gavi programmes. Comparable mechanism (bond issuance backed by sovereign members) with overlapping regional impact footprint.

Direct peers

• Gavi, the Vaccine Alliance: Gavi is IFFIm's sole programmatic beneficiary and most directly comparable organisation: a public-private partnership that channels donor and capital-markets funding (including from IFFIm) into immunisation programmes in low-income countries. Both share the same donor pool, mission and impact metrics.
• Global Fund to Fight AIDS, Tuberculosis and Malaria: Like IFFIm, the Global Fund is a public-private partnership raising multi-billion-dollar pools from sovereign donors to finance health programmes in low-income countries. It uses innovative finance (e.g., Debt2Health, AMFm) and replenishment cycles analogous to Gavi's.

Others

• Bill & Melinda Gates Foundation: The Gates Foundation is a major private philanthropic funder of Gavi and global immunisation, sitting in IFFIm's broader funding ecosystem. Comparable as a large-scale impact-capital provider for vaccine delivery, though structured as a foundation rather than a bond issuer.

Emerging players

• Coalition for Epidemic Preparedness Innovations (CEPI): CEPI is a direct recent recipient of IFFIm proceeds (the 2024 $1B issuance also funded CEPI). It is a comparable global-health financing entity pooling sovereign and donor capital for vaccine development against epidemic threats.

Market position

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/iffim

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Finance Facility for Immunisation